Metraipolis › archive › dc_b6dd71e4fe2c
Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States — Europe PMC PMID:41564730
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41564730
- DOI
- 10.1016/j.jacadv.2025.102517
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T16:49:44.093Z
- SHA-256 of the archived text
fc291676a8742a87505805ff5508ac9393158d8e7f4b678a9672d6a01ba18f82- Stable URL of this page
https://metraipolis.com/documento/dc_b6dd71e4fe2c
How to cite
Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States — Europe PMC PMID:41564730 — Europe PMC (en), https://europepmc.org/article/MED/41564730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6dd71e4fe2c (Metraipolis archive dc_b6dd71e4fe2c, sha256 fc291676a8742a87505805ff5508ac9393158d8e7f4b678a9672d6a01ba18f82)
BibTeX
@misc{dcb6dd71e4fe2c,
title = {Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States — Europe PMC PMID:41564730},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41564730},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6dd71e4fe2c; sha256 fc291676a8742a87505805ff5508ac9393158d8e7f4b678a9672d6a01ba18f82},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41564730. Agents can read the archived copy with the MCP tool read_document.